• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔瓦塞特大区 VI 卫生区域内新冠病毒检测呈阳性的成年人的严重程度和死亡率的危险因素。

Risk factors for severity and mortality in adults testing positive for COVID-19 in the VI Health Area of Albacete.

机构信息

Unidad de Arritmias de Cardiología, Hospital General de Albacete, Albacete, Spain.

Centro de Salud Zona VI, Albacete, Spain.

出版信息

Enferm Clin (Engl Ed). 2022 Jul-Aug;32(4):217-224. doi: 10.1016/j.enfcle.2022.01.003. Epub 2022 May 28.

DOI:10.1016/j.enfcle.2022.01.003
PMID:35636671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9142178/
Abstract

OBJECTIVES

There are several retrospective studies that establish a relationship between some risk factors (cardiovascular risks mainly) and the development of COVID-19 and a severe outcome. Thus, our aim with this study is to find out the former relationship among the population within our basic health area METHOD: Cohort study. The study sample consisted of 372 patients aged 14 or older who had tested positive for COVID-19 in our health centre by consecutive sampling. Data collected from medical records will be analysed using Frequencies, X2 with a Confidence interval of 95% and those carrying out the study will have prior experience/training in research and will be specifically trained for the aim of this research.

RESULTS

A worse outcome in patients aged 76 years old on average was found versus patients aged 48.7. Regarding high blood pressure patients, X2 was <0.001 and OR between 3.975 and 21.425 with confidence interval of 95%, finding a worse outcome in these patients. With regard to Diabetes Mellitus (DM), X2 was <0.001 and OR rated between 2.766 and 12.690 with a confidence interval of 95%, also resulting in a worse outcome in these patients. No significant differences regarding a worse outcome were found in Body Mass Index, gender, or toxic habits.

CONCLUSIONS

Older patients had a worse outcome from COVID-19, as well as patients with high blood pressure or DM. We found no differences regarding gender and neither could we find any differences regarding BMI.

摘要

目的

有几项回顾性研究确立了一些风险因素(主要是心血管风险)与 COVID-19 的发展和严重后果之间的关系。因此,我们这项研究的目的是在我们的基本医疗区域内的人群中找出以前的关系。

方法

队列研究。研究样本由通过连续抽样在我们的健康中心检测出 COVID-19 呈阳性的 372 名 14 岁或以上的患者组成。将从病历中收集的数据进行分析,使用频率、X2 和 95%置信区间,进行研究的人员将具有研究经验/培训,并且将专门针对这项研究进行培训。

结果

发现平均年龄为 76 岁的患者的预后比年龄为 48.7 岁的患者差。对于高血压患者,X2 <0.001,OR 为 3.975 至 21.425,95%置信区间,这些患者的预后较差。对于糖尿病(DM),X2 <0.001,OR 为 2.766 至 12.690,95%置信区间,这些患者的预后也较差。在体重指数、性别或有毒习惯方面,没有发现预后较差的显著差异。

结论

年龄较大的患者 COVID-19 的预后较差,高血压或 DM 患者也是如此。我们在性别方面没有发现差异,也没有在 BMI 方面发现差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/13a665803e6a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/ad4e66edb641/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/40182ebaa31b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/edf3628dd265/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/67aef0cddc76/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/13a665803e6a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/ad4e66edb641/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/40182ebaa31b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/edf3628dd265/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/67aef0cddc76/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f68/9142178/13a665803e6a/gr5_lrg.jpg

相似文献

1
Risk factors for severity and mortality in adults testing positive for COVID-19 in the VI Health Area of Albacete.阿尔瓦塞特大区 VI 卫生区域内新冠病毒检测呈阳性的成年人的严重程度和死亡率的危险因素。
Enferm Clin (Engl Ed). 2022 Jul-Aug;32(4):217-224. doi: 10.1016/j.enfcle.2022.01.003. Epub 2022 May 28.
2
[Risk factors for severity and mortality in adults testing positive for COVID-19 in the VI Health Area of Albacete].[阿尔巴塞特第六卫生区新冠病毒检测呈阳性的成年人病情严重程度及死亡率的风险因素]
Enferm Clin. 2022 Jul-Aug;32(4):217-224. doi: 10.1016/j.enfcli.2022.01.005. Epub 2022 Feb 3.
3
Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study.加纳住院 COVID-19 合并 2 型糖尿病患者的临床和实验室特征及转归:一项单中心研究。
Endocrinol Diabetes Metab. 2023 Jan;6(1):e391. doi: 10.1002/edm2.391. Epub 2022 Nov 25.
4
Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.沙特阿拉伯住院患者中的糖尿病和新冠病毒-19:一项单中心回顾性研究。
Cardiovasc Diabetol. 2020 Dec 5;19(1):205. doi: 10.1186/s12933-020-01184-4.
5
Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.1 型和 2 型糖尿病患者 COVID-19 病死率的危险因素:俄罗斯联邦 235248 例患者的全国回顾性队列研究。
Front Endocrinol (Lausanne). 2022 Aug 9;13:909874. doi: 10.3389/fendo.2022.909874. eCollection 2022.
6
High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study.纤维化 4 指数与 COVID-19 合并糖尿病患者的临床结局不良相关:一项多中心观察性研究。
Endocrinol Metab (Seoul). 2021 Aug;36(4):800-809. doi: 10.3803/EnM.2021.1040. Epub 2021 Aug 20.
7
Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City.COVID-19 成年住院患者死亡率的预测因素:来自纽约市的回顾性队列研究。
West J Emerg Med. 2020 Jul 8;21(4):779-784. doi: 10.5811/westjem.2020.6.47919.
8
Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.尼日利亚拉各斯 COVID-19 患者合并与不合并高血压的发病率和死亡率结局:一项回顾性队列研究。
Glob Health Res Policy. 2021 Jul 29;6(1):26. doi: 10.1186/s41256-021-00210-6.
9
Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.住院的 COVID-19 患者中合并与不合并糖尿病患者的特征和结局。
Diabetes Metab Res Rev. 2021 Mar;37(3):e3388. doi: 10.1002/dmrr.3388. Epub 2020 Aug 18.
10
Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.糖尿病和高血压对 COVID-19 感染严重程度和死亡率的有害影响:来自印度的一项多中心病例对照研究。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102248. doi: 10.1016/j.dsx.2021.102248. Epub 2021 Aug 15.

本文引用的文献

1
Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review.肥胖作为 COVID-19 重症和并发症的风险因素:综述。
Cells. 2021 Apr 17;10(4):933. doi: 10.3390/cells10040933.
2
Excess body weight is an independent risk factor for severe forms of COVID-19.超重是 COVID-19 严重症状的一个独立危险因素。
Metabolism. 2021 Apr;117:154703. doi: 10.1016/j.metabol.2021.154703. Epub 2021 Jan 6.
3
Interrelations between COVID-19 and other disorders.新型冠状病毒肺炎与其他疾病的相互关系。
Clin Immunol. 2021 Mar;224:108651. doi: 10.1016/j.clim.2020.108651. Epub 2020 Dec 14.
4
Survival in adult inpatients with COVID-19.COVID-19 成年住院患者的生存情况。
Public Health. 2021 Jan;190:1-3. doi: 10.1016/j.puhe.2020.10.029. Epub 2020 Nov 10.
5
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.全球 COVID-19 荟萃分析显示,男性性别是死亡和 ICU 入院的风险因素。
Nat Commun. 2020 Dec 9;11(1):6317. doi: 10.1038/s41467-020-19741-6.
6
Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis.肥胖与 COVID-19 肺炎疾病严重程度增加相关:系统评价和荟萃分析。
Eur J Med Res. 2020 Dec 2;25(1):64. doi: 10.1186/s40001-020-00464-9.
7
Risk Factors for COVID-19.新型冠状病毒肺炎的风险因素。
Infez Med. 2020 Dec 1;28(4):469-474.
8
Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain.西班牙 COVID-19 住院超高龄患者的临床特征和死亡危险因素。
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e28-e37. doi: 10.1093/gerona/glaa243.
9
Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities.男性 COVID-19 死亡率较高:免疫反应和心血管合并症的性别差异。
Cardiovasc Res. 2020 Dec 1;116(14):2197-2206. doi: 10.1093/cvr/cvaa284.
10
Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.韩国调整年龄和性别后 COVID-19 的病死率:整个疫情期间死亡率估计风险的演变。
Int J Infect Dis. 2020 Dec;101:306-311. doi: 10.1016/j.ijid.2020.09.1478. Epub 2020 Oct 2.